NDC 65044-6514

Insects Whole Body, Ant, Fire Solenopsis richteri

Ant, Fire Solenopsis Richteri

Insects Whole Body, Ant, Fire Solenopsis richteri is a Percutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Jubilant Hollisterstier Llc. The primary component is Solenopsis Richteri.

Product ID65044-6514_480a1366-e97c-4bea-976d-d1906ba489c6
NDC65044-6514
Product TypeNon-standardized Allergenic
Proprietary NameInsects Whole Body, Ant, Fire Solenopsis richteri
Generic NameAnt, Fire Solenopsis Richteri
Dosage FormInjection, Solution
Route of AdministrationPERCUTANEOUS
Marketing Start Date1941-04-19
Marketing CategoryBLA / BLA
Application NumberBLA103888
Labeler NameJubilant HollisterStier LLC
Substance NameSOLENOPSIS RICHTERI
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Insect Venom Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [CS],Ant Venoms [CS],Allergens [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65044-6514-1

5 mL in 1 VIAL (65044-6514-1)
Marketing Start Date1941-04-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65044-6514-1 [65044651401]

Insects Whole Body, Ant, Fire Solenopsis richteri INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103888
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1941-04-19
Marketing End Date2018-06-29

Drug Details

Active Ingredients

IngredientStrength
SOLENOPSIS RICHTERI.1 g/mL

Pharmacological Class

  • Non-Standardized Insect Venom Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Insect Proteins [CS]
  • Ant Venoms [CS]
  • Allergens [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.